Onconetix Inc. is a commercial-stage biotechnology company focused on solutions for men’s health and oncology. The company develops and commercializes proprietary therapeutics, diagnostics, and clinician-focused services, with an emphasis on prostate cancer and related urologic conditions. Its product portfolio includes Proclarix, a blood-based diagnostic test used in prostate cancer assessment, and Entadfi, an oral therapy for benign prostatic hyperplasia. Onconetix also works on expanding its oncology diagnostics and treatment offerings through research, development, and commercialization activities across key international markets, including the United States and Europe. Headquartered in Cincinnati, Ohio, Onconetix Inc. operates at the intersection of diagnostic testing and therapeutic care, serving healthcare providers and patients in specialized cancer and men’s health settings.
Website201 East Fifth Street
Cincinnati, OH, 45202
United States
Gainers Onconetix (NASDAQ:ONCO) stock increased by 10.3% to $1.14 during Friday's after-market session. The market value of their outstanding shares is at $3.9 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved
Gainers Prime Medicine (NASDAQ:PRME) shares increased by 13.0% to $3.47 during Thursday's after-market session. The market value of their outstanding shares is at $567.7 million. Onconetix (NASDAQ:ONCO) stock rose
SRX Global (SRXH) said Thursday it has made an investment in Onconetix (ONCO), which is in the midst
Initial Advance of $2.5 Million to Realbotix LLC to Support Growth and Working Capital; Non-Interest Bearing Facility Is Automatically Cancelled and Discharged in Full Upon Closing of Pending Acquisition CINCINNATI, Ohio, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") today announced that it has provided a strategic bridge financing facility of up to $5,000,000 to Realbotix LLC ("Realbotix"), the target of its previously announced pending acquisi
Investors talking about ONCO also mention
What share of all stock conversation is about ONCO?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% -0.02 | 0.01% +0.01 | 0% +0 | 0% 0 |
Of the messages about ONCO that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 66.67% -31.77 | 76.46% -23.54 | 72.51% -25.6 | 78.57% -8.54 | ||
| Bearish | 33.33% +31.77 | 23.54% +23.54 | 27.49% +25.6 | 21.43% +8.54 |
Of the messages about ONCO that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 0% | 24.39% | 20.81% | 49.44% | ||
| Technical Analysis | 100% | 2.44% | 2.35% | 31.99% | ||
| Analysts | 0% | 36.59% | 37.92% | 9.08% | ||
| Macro | 0% | 36.59% | 37.92% | 9.08% | ||
| Controversies | 0% | 0% | 1.01% | 0.32% | ||
| Earnings | 0% | 0% | 0% | 0.08% |
Of the messages about ONCO, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 52.94% | 35.83% | 36.09% | 22.18% | ||
| Newcomers | 47.06% | 64.17% | 63.91% | 77.82% |